
|Articles|October 5, 2018
AJMC® in the Press, October 5, 2018
Author(s)AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
Advertisement
An article from
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
SENTRY Trial Shows Survival, Spleen Benefits in Myelofibrosis: Claire Harrison, MD
3
Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD
4
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
5




